News for 'Oxford University'

Oxfordwallahs love papads!

Oxfordwallahs love papads!

Rediff.com19 Jan 2015

Indian kitchen goes global as 'keema', 'papad' are now included in the Oxford English Dictionary for the first time.

Modi's khaas dost Johnson set India-UK ties on comprehensive course

Modi's khaas dost Johnson set India-UK ties on comprehensive course

Rediff.com7 Jul 2022

His visit to India followed a few cancelled plans since he took office in July 2019 due to the coronavirus pandemic crisis, with the two leaders holding several virtual talks and eventually meeting in person on the sidelines of the COP26 climate summit in Glasgow last November.

PM to visit 3 COVID-19 vaccine development sites on Saturday

PM to visit 3 COVID-19 vaccine development sites on Saturday

Rediff.com27 Nov 2020

Modi on Saturday will embark on a three-city tour to take stock of the COVID-19 vaccine development work.

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Rediff.com11 Sep 2020

The DCGI also directed Serum Institute of India to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

'The idea of Modi in power fills us with dread'

'The idea of Modi in power fills us with dread'

Rediff.com23 Apr 2014

Around 75 professors and other academics of Indian origin working at some of Britain's prestigious institutions such as Cambridge and Oxford university and London School of Economics on Tuesday issued an open letter, sharply attacking Narendra Modi and saying, "The idea of Modi in power fills us with dread".

UK signs deal for 90 million COVID-19 vaccine doses

UK signs deal for 90 million COVID-19 vaccine doses

Rediff.com20 Jul 2020

To enable large-scale vaccine studies to take place across the UK, the aim is to get 500,000 people signed up by October, which is considered vital in the fight against coronavirus.

India 'Stay Calm' About Kraken: Experts

India 'Stay Calm' About Kraken: Experts

Rediff.com16 Jan 2023

The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.

COVID-19 vaccine may never be found, warns UK PM

COVID-19 vaccine may never be found, warns UK PM

Rediff.com12 May 2020

Admitting that a vaccine or drug-based treatment is the only feasible long-term solution, he said the UK has accelerated this with promising vaccine development programmes and a collaboration between Oxford University and pharma major AstraZeneca was a vital step that could help rapidly advance the manufacture of a Covid-19 vaccine when it is ready.

WHO nod for Covaxin expected any time now

WHO nod for Covaxin expected any time now

Rediff.com26 Oct 2021

A technical advisory group of the World Health Organisation was on Tuesday reviewing data on Covaxin for the emergency use listing of India's indigenously-made vaccine and it could pronounce its decision within the next 24 hours or so, a spokesperson said.

UK identifies new South African coronavirus variant

UK identifies new South African coronavirus variant

Rediff.com24 Dec 2020

Like the UK variant identified earlier, the new variant of the novel coronavirus is also driving a massive resurgence of the disease in South Africa, with experts warning the country is probably facing a much larger second wave.

10 things to know about COVID-19 vaccines

10 things to know about COVID-19 vaccines

Rediff.com16 Jan 2021

As India holds its breath for the Covid vaccination to be begin, Sudhir Bisht provides a quick checklist of what you must know about the vaccines that will be administered to citizens.

Narayana Murthy's son-in-law wants Britain to leave EU

Narayana Murthy's son-in-law wants Britain to leave EU

Rediff.com20 May 2016

The Oxford University and Stanford MBA graduate co-founded a 1-billion-pound global investment firm and specialised in investing in small British businesses

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

'Covishield to be sold in private market for Rs 1,000 per dose'

'Covishield to be sold in private market for Rs 1,000 per dose'

Rediff.com12 Jan 2021

Adar Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable groups of people and to healthcare workers".

Trio wins Medicine Nobel for work on how cells use oxygen

Trio wins Medicine Nobel for work on how cells use oxygen

Rediff.com7 Oct 2019

Their discoveries pave the way for promising new strategies to fight anemia, cancer and several other diseases.

WHO chief thanks PM for support to global COVID response

WHO chief thanks PM for support to global COVID response

Rediff.com23 Jan 2021

Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. He said last week India was ready to do everything possible for a healthy planet.

Sensex ends 195 pts higher; Nifty tops 12,900

Sensex ends 195 pts higher; Nifty tops 12,900

Rediff.com23 Nov 2020

ONGC was the top gainer in the Sensex pack, surging around 7 per cent, followed by IndusInd Bank, Infosys, Tech Mahindra, Reliance Industries, HCL Tech and TCS. On the other hand, HDFC, ICICI Bank, Axis Bank, SBI and M&M were among the laggards.

Serum Institute's race to produce COVID-19 vaccine

Serum Institute's race to produce COVID-19 vaccine

Rediff.com23 May 2020

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'

Serum Institute halts COVID-19 vaccine trials in India

Serum Institute halts COVID-19 vaccine trials in India

Rediff.com10 Sep 2020

Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study.

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Preliminary data shows Vaxzevria booster works against Omicron: AstraZeneca

Rediff.com13 Jan 2022

The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.

50 lakh Covishield doses meant for export to UK to be used in India

50 lakh Covishield doses meant for export to UK to be used in India

Rediff.com8 May 2021

50 lakh doses of 'Covishield' vaccine earmarked by the Serum Institute for export to the United Kingdom have now been made available for the inoculation of 18-44 age group in 21 states/UTs in India, amid a surge in COVID-19 cases, official sources said.

Sensex, Nifty extend record run on vaccine booster

Sensex, Nifty extend record run on vaccine booster

Rediff.com30 Dec 2020

Among major Sensex movers, Ultratech Cement rose over 4 per cent, Bajaj Finance by 2.63 per cent and Maruti by 2 per cent. BSE Sensex closed up by 133.14 points at a record high of 47,746.22. NSE Nifty rose by 49.35 points at its lifetime high of 13,981.95.

WHO seeks 'additional clarifications' from Bharat Biotech

WHO seeks 'additional clarifications' from Bharat Biotech

Rediff.com27 Oct 2021

The technical advisory group will now meet on November 3 for a final assessment.

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

AstraZeneca's vaccine reaches phase 3 clinical trials: Trump

Rediff.com1 Sep 2020

The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.

Study in the UK: The best universities for students

Study in the UK: The best universities for students

Rediff.com10 Apr 2015

The survey, conducted by the Times Higher Education (THE), ranks universities according to 21 parameters that enhance student experience.

India trade deal eludes another British prime minister

India trade deal eludes another British prime minister

Rediff.com20 Oct 2022

Britain's third female prime Minister, Liz Truss, was out of office on Thursday after the shortest tenure at 10 Downing Street in London and without a cherished India-UK free trade agreement (FTA) under her belt as a Brexit prize.

Noted economist Abhijit Sen, advocate of MSP, passes away

Noted economist Abhijit Sen, advocate of MSP, passes away

Rediff.com30 Aug 2022

Economist Abhijit Sen, a former Planning Commission member and one of the country's foremost experts on rural economy, died on Monday night. He was 72.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

World's stunning college campuses

World's stunning college campuses

Rediff.com7 Jan 2015

Who would want to study in a classroom when you have such a gorgeous campus around you?

Serum Institute to produce COVID-19 vaccine by yearend

Serum Institute to produce COVID-19 vaccine by yearend

Rediff.com7 May 2020

'The challenge will be making sure its efficacy is high.' 'If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.'

Germany, France, Italy suspend use of AstraZeneca vaccine

Germany, France, Italy suspend use of AstraZeneca vaccine

Rediff.com15 Mar 2021

The British-Swedish pharmaceutical major and the UK's medicines regulator said that the vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe.

'Grave concerns' about Trump's mental stability: Harvard doctors

'Grave concerns' about Trump's mental stability: Harvard doctors

Rediff.com20 Dec 2016

In the letter addressed to the US president, the doctors -- one from the Harvard Medical School and two others who have been associated with top US varsities over the years - have urged him to order a "full medical and neuropsychiatric evaluation" before the President-elect takes office on January 20.

India pulled 415 million people out of poverty in 15 years: UN

India pulled 415 million people out of poverty in 15 years: UN

Rediff.com11 Jul 2023

A total of 415 million people moved out of poverty in India within just 15 years from 2005/2006 to 2019/2021, the United Nations said on Tuesday, highlighting the remarkable achievement by the world's most populous nation.

UK's PM-in-waiting Liz Truss remains committed to India ties

UK's PM-in-waiting Liz Truss remains committed to India ties

Rediff.com5 Sep 2022

Newly-elected Conservative Party leader and prime minister in waiting Liz Truss is among the senior British politicians known for championing deeper India-UK strategic and economic ties, describing them as a "sweet spot" of global trade dynamics.

India's Sputnik V decision a win for Russia's soft power diplomacy

India's Sputnik V decision a win for Russia's soft power diplomacy

Rediff.com20 Apr 2021

The Russian vaccine has been registered in more than 55 countries and is gaining recognition in the virtual world -- being the only to have its own Facebook page, YouTube channel and a Twitter handle, reports Aneesh Phadnis

Happy to be part of noble effort: Covid vaccine volunteer

Happy to be part of noble effort: Covid vaccine volunteer

Rediff.com27 Aug 2020

The volunteer said he had also volunteered 10 years ago for clinical trials for a vaccine against the H1N1 (swine flu) virus.

Mixing different vaccines produces better immune response: Study

Mixing different vaccines produces better immune response: Study

Rediff.com7 Dec 2021

Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs generates robust immune response against COVID-19, according to a study published in The Lancet journal.

India's vaccine makers prepare to take on Omicron

India's vaccine makers prepare to take on Omicron

Rediff.com8 Dec 2021

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

British Indian doc's call for Delhi to suspend Covishield use finds support

British Indian doc's call for Delhi to suspend Covishield use finds support

Rediff.com6 Feb 2023

A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.